MedPath

Prevalence of adrenal insufficiency and thyroid dysfunction in post COVID-19 infectio

Recruiting
Conditions
adrenal insufficiency thyroid dysfunctionpost-covid-19 patients
adrenal insufficiency
thyroid dysfunction
post-covid-19 patients
Registration Number
TCTR20220606002
Lead Sponsor
Chulabhorn Royal Academy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
92
Inclusion Criteria

Post covid-19 patients, 3 months apart

Exclusion Criteria

on glucocorticoid therapy
History of adrenal disease or pituitary disease
chronic kidney disease (Creatinine > 1.5 mg/dl)
chronic liver disease
on medication such as anti epileptic drugs or oral contraceptive drug
pregnancy or lactation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prevalence of adrenal insufficiency 3 months low dose ACTH stimulation test
Secondary Outcome Measures
NameTimeMethod
thyroid dysfunction 3 months thyroid stimulating hormone
© Copyright 2025. All Rights Reserved by MedPath